A detailed history of Cwm, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Cwm, LLC holds 319 shares of CSTL stock, worth $8,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares
319
Previous 117 172.65%
Holding current value
$8,766
Previous $3,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$17.4 - $31.47 $3,514 - $6,356
202 Added 172.65%
319 $9,000
Q2 2024

Jul 09, 2024

BUY
$18.84 - $24.94 $1,978 - $2,618
105 Added 875.0%
117 $3,000
Q1 2024

Apr 05, 2024

BUY
$18.06 - $25.3 $216 - $303
12 New
12 $0
Q3 2023

Oct 11, 2023

BUY
$13.28 - $20.3 $332 - $507
25 New
25 $0
Q2 2022

Jul 28, 2022

SELL
$16.0 - $45.99 $320 - $919
-20 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$33.17 - $46.98 $597 - $845
18 Added 900.0%
20 $1,000
Q4 2021

Jan 31, 2022

BUY
$39.06 - $67.58 $78 - $135
2 New
2 $0

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $723M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.